We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Low-Dose CT Monitoring of Lung Nodules Could Spare Unnecessary Surgery

By MedImaging International staff writers
Posted on 04 Sep 2015
Image: CT images show invasive adenocarcinoma of the lung (photo courtesy of RSNA).
Image: CT images show invasive adenocarcinoma of the lung (photo courtesy of RSNA).
A new study shows that non-solid lung nodules can be safely monitored by performing annual low-dose Computed Tomography (CT) screening.

Non-solid nodules often show up on chest CT scans, and may result in additional imaging tests or surgery. Annual low-dose CT screening could spare patients unnecessary interventions and imaging.

The study was performed by researchers at the Icahn School of Medicine at Mount Sinai Hospital (ISMMS; New York, NY, USA) and included 57,496 participants from the International Early Lung Cancer Program (I-ELCAP). The patients received one baseline, and repeat screenings every subsequent year, during which time the researchers evaluated any non-solid nodules found.

The results of the research suggest that non-solid nodules can be safely followed using annual low-dose CT screening, and can help clinicians assess a potential transition to a part-solid nodule.

Study coauthor Claudia I. Henschke, PhD, MD, Icahn School of Medicine, said, "Nonsolid nodules could be due to inflammation, infection or fibrosis, but could also be cancerous or a precursor of cancer. For screening, we have to define which nodules need further workup and how quickly we have to do that workup. The results show that if we see a nonsolid lung nodule of any size, we can tell people to come back in one year for another CT. These findings are important for reducing unnecessary CT scans and possible biopsies or surgery in programs of CT screening for lung cancer."

The study was published online, in the journal Radiology on July 23, 2015.

Related Links:

Icahn School of Medicine


Mammography System (Analog)
MAM VENUS
High-Precision QA Tool
DEXA Phantom
40/80-Slice CT System
uCT 528
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.